NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- American Oriental Bioengineering Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, today announced that the company will attend the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at the Grand Hyatt Hotel in New York. Management is currently scheduled to meet with institutional investors and to present at 2:20 pm ET on February 6, 2008. Listeners may access a live webcast of the presentation by visiting the investor relations section of the Company's website at http://www.bioaobo.com/.
For more information about the conference, please contact your Merrill Lynch sales representative.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a leading, fully integrated, plant based pharmaceutical and plant based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant based products in China. For more information, visit http://www.bioaobo.com.
|SOURCE American Oriental Bioengineering Inc.|
Copyright©2008 PR Newswire.
All rights reserved